Does remote reprogramming of insertable cardiac monitors reduce transmission burden in patients?
Remote reprogramming of insertable cardiac monitors is utilized in 39% of real-world cases and can significantly reduce remote monitoring transmission burden.
Background: Insertable cardiac monitors (ICMs) enable continuous arrhythmia monitoring but generate high transmission volumes, increasing clinical workload. The LUX-Dx ICM (Boston Scientific) allows remote reprogramming of device alert settings, potentially reducing in-office visits. Objective: This study aimed to evaluate the real-world use of remote reprogramming after its initial commercialization in Europe and its impact on transmission burden. Methods: Deidentified data were collected from 697 consecutive patients across 23 European centers between 2022 and 2024. Results: < .001). Conclusion: ICM reprogramming plays a key role in optimizing device performance and reducing remote monitoring burden. Currently used in 39% of cases, remote reprogramming holds potential for broader adoption to minimize in-office visits. Efficiency may be further improved by transitioning to an alert-based monitoring strategy and eliminating scheduled transmissions.
Fareh et al. (Mon,) studied this question.